Nadya is pursuing her PhD in molecular biology, specialising in antibody discovery.

Nadya is currently trying to develop platform methodologies for antibody discovery. The focus of her PhD project is to identify candidate antibodies agains type I and type III membrane proteins, and to streamline the process for biopharmaceutical development.  She also works as a part time research assistant, investigating how the innate immune response contibutes to tumour progression. 

​Nadya Panagides obtained her undergraduate degree in Biomedical Sciences with a sub-major in Genetics from the University of Queensland.  She successfully completed two summer semester research projects, and was awarded first class honours for her work in the Venom Evolution Laboratory, under the supervision of Associate professor Bryan Fry. Her venom based research involved proteomically characterising a variety of African viper and cobra venoms, and for her honours thesis in particular, assessing their toxicological activity and potential as anti-cancer agents. She continued her work with venom toxins by volunteering at the QIMR Berghofer Medical Research Institute, by working in Dr John Miles' Human Immunity Laboratory under the supervision of Dr Maria Ikonomopoulou. She began to develop a keen interest in immunology and started working as a Research Assistant in Dr Barbara Rolfe's laboratory at the AIBN, where her research focus shifted to cancer immunology, and more specifically the role of complement components C3a and C5a in tumour progression. Nadya was awarded the ARC Training Centre in Biopharmaceutical Innovation PhD scholarship. 

Industry Engagement

​Nadya's PhD project is associated with CSL

Key Publications

Panagides N., Jackson T.N.W., Pretzler R., Ikonomopoulou M., Arbuckle K., Yang D.C., Ali S.A., Koludarov I., Dobson J., Sanker B., Asselin A., Castro R., Hendrix I., Van Der Ploeg H., Tai-a-pin J., Van Den Bergh R., Kerkkamp H., Vonk F.J., Naude A., Strydom M., Jacobsz L., Dunstan N., Jaeger M., Hodgson W.C., Miles J., Fry B.G. (2017) How the cobra got its venom: cytotoxicity as a defensive innovation and its co-evolution with hooding and spitting. Toxins 9; 103.

Santana R., Perez D., Dobson J., Panagides N., Raven R., Nouwens A., Jones A., King G., Fry B.G. (2017) Venom profiling of a population of the theraphosid spider Phlogius crassipes reveals continuous ontogenetic changes from juveniles through adulthood. Toxins 9; 116. 

Jesupret C., Baumann K., Jackson T.N.W., Ali S.A., Yang D.C., Greisman L., Kern L., Steuten J., Jouiaei M., Casewell N.R., Undheim E.A.B., Koludarov I., Debono J., Low D.H.W., Rossi S., Panagides N., Winter K., Ignjatovich V., Summerhayes R., Jones A., Nouwens A., Dunstan N., Hodgson W.C., Winkel K.D., Monagle P., Fry B.G. (2014) Vintage Venoms: Proteomic and Pharmacological Stability of Snake Venoms Stored for Up to Eight Decades. Journal of Proteomics 105; 285-295.